These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 28676432)

  • 21. Major depressive disorder and cardiometabolic disease risk among sub-Saharan African adults.
    Gelaye B; Williams MA; Lemma S; Berhane Y; Fann JR; Vander Stoep A; Zhou XH
    Diabetes Metab Syndr; 2015; 9(3):183-91. PubMed ID: 25470634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Major depressive disorder in vulnerable groups of older adults, their course and treatment, and psychiatric comorbidity.
    Chou KL; Cheung KC
    Depress Anxiety; 2013 Jun; 30(6):528-37. PubMed ID: 23423971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of depression on workplace functioning and disability costs.
    Katon W
    Am J Manag Care; 2009 Dec; 15(11 Suppl):S322-7. PubMed ID: 20088628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors associated with major depressive disorder occurring after the onset of obsessive-compulsive disorder.
    Besiroglu L; Uguz F; Saglam M; Agargun MY; Cilli AS
    J Affect Disord; 2007 Sep; 102(1-3):73-9. PubMed ID: 17222458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Depression and associated organic pathologies, a still under-estimated comorbidity. Results of the DIALOGUE study].
    Consoli SM;
    Presse Med; 2003 Jan; 32(1):10-21. PubMed ID: 12610390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Employer burden of mild, moderate, and severe major depressive disorder: mental health services utilization and costs, and work performance.
    Birnbaum HG; Kessler RC; Kelley D; Ben-Hamadi R; Joish VN; Greenberg PE
    Depress Anxiety; 2010; 27(1):78-89. PubMed ID: 19569060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Overview of the Heterogeneity of Major Depressive Disorder: Current Knowledge and Future Prospective.
    Athira KV; Bandopadhyay S; Samudrala PK; Naidu VGM; Lahkar M; Chakravarty S
    Curr Neuropharmacol; 2020; 18(3):168-187. PubMed ID: 31573890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of life: the ultimate outcome measure of interventions in major depressive disorder.
    IsHak WW; Greenberg JM; Balayan K; Kapitanski N; Jeffrey J; Fathy H; Fakhry H; Rapaport MH
    Harv Rev Psychiatry; 2011; 19(5):229-39. PubMed ID: 21916825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comorbid depression, chronic pain, and disability in primary care.
    Arnow BA; Hunkeler EM; Blasey CM; Lee J; Constantino MJ; Fireman B; Kraemer HC; Dea R; Robinson R; Hayward C
    Psychosom Med; 2006; 68(2):262-8. PubMed ID: 16554392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated specific peripheral cytokines found in major depressive disorder patients with childhood trauma exposure: a cytokine antibody array analysis.
    Lu S; Peng H; Wang L; Vasish S; Zhang Y; Gao W; Wu W; Liao M; Wang M; Tang H; Li W; Li W; Li Z; Zhou J; Zhang Z; Li L
    Compr Psychiatry; 2013 Oct; 54(7):953-61. PubMed ID: 23639406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antidepressants for major depressive disorder in patients with a co-morbid axis-III disorder: a meta-analysis of patient characteristics and placebo response rates in randomized controlled trials.
    Iovieno N; Tedeschini E; Ameral VE; Rigatelli M; Papakostas GI
    Int Clin Psychopharmacol; 2011 Mar; 26(2):69-74. PubMed ID: 20962663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Diabetes Mellitus on Surgical Quality Measures After Ankle Fracture Surgery: Implications for "Value-Based" Compensation and "Pay for Performance".
    Regan DK; Manoli A; Hutzler L; Konda SR; Egol KA
    J Orthop Trauma; 2015 Dec; 29(12):e483-6. PubMed ID: 26595598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sleep architecture variation: a mediator of metabolic disturbance in individuals with major depressive disorder.
    Kudlow PA; Cha DS; Lam RW; McIntyre RS
    Sleep Med; 2013 Oct; 14(10):943-9. PubMed ID: 24001995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The direct costs of untreated comorbid insomnia in a managed care population with major depressive disorder.
    Asche CV; Joish VN; Camacho F; Drake CL
    Curr Med Res Opin; 2010 Aug; 26(8):1843-53. PubMed ID: 20515321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Why do you need to move beyond first-line therapy for major depression?
    Culpepper L
    J Clin Psychiatry; 2010; 71 Suppl 1():4-9. PubMed ID: 20977873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical guidelines for the treatment of depressive disorders, I. Definitions, prevalence, and health burden.
    Parikh SV; Lam RW;
    Can J Psychiatry; 2001 Jun; 46 Suppl 1():13S-20S. PubMed ID: 11441768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retention in psychiatric treatment in a Canadian sample of HIV-positive women.
    Sloan EP
    AIDS Care; 2014; 26(7):927-30. PubMed ID: 24367912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship of depression and diabetes: pathophysiological and treatment implications.
    Rustad JK; Musselman DL; Nemeroff CB
    Psychoneuroendocrinology; 2011 Oct; 36(9):1276-86. PubMed ID: 21474250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depression in patients with borderline personality disorder.
    Yoshimatsu K; Palmer B
    Harv Rev Psychiatry; 2014; 22(5):266-73. PubMed ID: 25188732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct and indirect costs of employees with treatment-resistant and non-treatment-resistant major depressive disorder.
    Ivanova JI; Birnbaum HG; Kidolezi Y; Subramanian G; Khan SA; Stensland MD
    Curr Med Res Opin; 2010 Oct; 26(10):2475-84. PubMed ID: 20825269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.